This topic contains a solution. Click here to go to the answer

Author Question: A client is receiving verteporfin treatment for macular degeneration. The nurse should instruct the ... (Read 86 times)

mia

  • Hero Member
  • *****
  • Posts: 564
A client is receiving verteporfin treatment for macular degeneration. The nurse should instruct the client in which of the following after the procedure?
 
  1. Flush the eyes with warm water twice a day
   2. Use artificial tears to keep the eyes moist
   3. Avoid sunlight or bright indoor light for 5 days after treatment
   4. Do not lift heavy objects for 2 weeks after the treatment

Question 2

Your client is in the hospital recovering from surgery and is in pain. The client's room is near your busy nurses' station, and the client has a talkative roommate.
 
  It is difficult for your client to concentrate to learn how to change the surgical dressing. What is your client most likely experiencing?
  1. sensory deprivation
  2. impaired verbal communication
  3. risk for injury
  4. sensory overload



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

xiaomengxian

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

3. Avoid sunlight or bright indoor light for 5 days after treatment

Rationale:
One treatment for macular degeneration is the use of verteporfin, a drug that tends to adhere to the surface of new blood vessels. This medication is injected systemically. Light is then shined into the affected eye, activating the drug and destroying new blood vessels. This treatment is relatively fast and painless, but does require avoidance of exposure to direct sunlight or bright indoor light for 5 days following treatment. Therefore, the nurse should instruct the client to avoid sunlight. Flushing the eyes with warm water, using artificial tears, or not lifting heavy objects for 2 weeks after treatment are not indicated for the verteporfin treatment.

Answer to Question 2

ANS: 4



mia

  • Hero Member
  • *****
  • Posts: 564
Both answers were spot on, thank you once again




 

Did you know?

Every flu season is different, and even healthy people can get extremely sick from the flu, as well as spread it to others. The flu season can begin as early as October and last as late as May. Every person over six months of age should get an annual flu vaccine. The vaccine cannot cause you to get influenza, but in some seasons, may not be completely able to prevent you from acquiring influenza due to changes in causative viruses. The viruses in the flu shot are killed—there is no way they can give you the flu. Minor side effects include soreness, redness, or swelling where the shot was given. It is possible to develop a slight fever, and body aches, but these are simply signs that the body is responding to the vaccine and making itself ready to fight off the influenza virus should you come in contact with it.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

There are immediate benefits of chiropractic adjustments that are visible via magnetic resonance imaging (MRI). It shows that spinal manipulation therapy is effective in decreasing pain and increasing the gaps between the vertebrae, reducing pressure that leads to pain.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library